Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Radiotherapy × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 177 Central Nervous System Neoplasms 104 Brain Neoplasms 89 Gliosarcoma 78 Glioma 58 Astrocytoma 52 Oligodendroglioma 29 Neuroblastoma 20 Neoplasm Metastasis 16 Medulloblastoma 16 Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 11 Breast Neoplasms 11 Diffuse Intrinsic Pontine Glioma 10 Ependymoma 8 Neoplasms 7 Meningeal Carcinomatosis 7 Squamous Cell Carcinoma of Head and Neck 5 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Follicular 5 Lymphoma 5 Esthesioneuroblastoma, Olfactory 5 Burkitt Lymphoma 5 Sarcoma 4 Salivary Gland Neoplasms 4 Recurrence 4 Rectal Neoplasms 4 Radiation Injuries 4 Optic Nerve Glioma 4

Interventions

Temozolomide 2 vorasidenib 1 pembrolizumab 1 pamiparib 1 cixutumumab 1 Vorinostat 1 Vincristine 1 Valproic Acid 1 Thiotepa 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Oncolytic Virotherapy 1 ONC206 1 Melphalan 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Cisplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Antibodies, Monoclonal 1 Aminolevulinic Acid 1 Amifostine 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡